Screening and identification of a novel antidiabetic peptide from collagen hydrolysates of Chinese giant salamander skin: network pharmacology, inhibition kinetics and protection of IR-HepG2 cells
Ming Zhou, Guoyan Ren, Bin Zhang, Fuli Ma, Jinling Fan, Zhijun Qiu
Abstract
experiments showed that GPPGPA as a competitive inhibitor could effectively inhibit the activity of α-glucosidase. The results of the IR-HepG2 cell model experiments showed that GPPGPA was not toxic to HepG2 cells, and could reduce IR of HepG2 cells induced by high-glucose and high-insulin, improve glucose consumption, increase the activity of superoxide dismutase (SOD), and reduce the content of malondialdehyde (MDA). The above results suggested that GPPGPA could improve T2DM by reducing insulin resistance through a multi-target and multi-pathway mechanism. GPPGPA could be developed and utilized as a novel hyperglycemic inhibitor in functional food.
Topics & Concepts
PharmacologyPI3K/AKT/mTOR pathwayInsulin resistanceProtein kinase BSuperoxide dismutaseOxidative stressSignal transductionChemistryBiologyInsulinCell biologyBiochemistryEndocrinologyProtein Hydrolysis and Bioactive PeptidesComputational Drug Discovery MethodsPhytochemicals and Antioxidant Activities